Back

Do we need trials to account for sex differences in HFpEF?

24 May 2022 (08:45 - 09:00)
Organised by:
Congress Presentation Part of: What next for trials in heart failure with preserved ejection fraction? Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

3 More presentations in this session

Presentation thumbnail
Similarities and differences between SGLT2i trials in HFpEF
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
Do we need trials of combination pharmacotherapy?
Professor N. Sato (Kawaguchi, JP)
Slides Video
Presentation thumbnail
What next for trials in heart failure with preserved ejection fraction? - discussion.
Video

Access the full session

Session thumbnail
What next for trials in heart failure with preserved ejection fraction?
Video

The Event

Event poster

Heart Failure 2022

24 May 2022 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Enrollment of women heart failure trials – progress made, innovative next steps.
29 August 2022
thumbnail
Congress Presentation
Sex-based differences in HFpEF: phenotyping and biological implications.
21 May 2022
thumbnail
Congress Presentation
ICDs and CRTs
20 May 2023
thumbnail
Congress Presentation
Consistent efficacy of vutrisiran across sexes in transthyretin cardiac amyloidosis: evidence from the HELIOS-B trial
11 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources